European Journal of Chemistry 2014, 5(3), 469-474 | doi: https://doi.org/10.5155/eurjchem.5.3.469-474.1058 | Get rights and content

Issue cover





  Open Access OPEN ACCESS | Open Access PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS

Development and validation of a new RP-HPLC method for the determination of process related impurities in pioglitazone hydrochloride


Venkata Raj Kumar Prava (1,*) , Ganapaty Seru (2)

(1) Department of Pharmaceutical Sciences, Andhra University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, 530003, Andhra Pradesh, India
(2) Gitam Institute of Pharmacy, Gitam University, Rushikonda, Visakhapatnam, 530045, Andhra Pradesh, India
(*) Corresponding Author

Received: 22 Mar 2014 | Revised: 03 May 2014 | Accepted: 04 May 2014 | Published: 30 Sep 2014 | Issue Date: September 2014

Abstract


A reversed phase high performance liquid chromatographic method for the determination of process related impurities in pioglitazone hydrochloride was developed and validated. High-quality separation was achieved on a Luna C18 column (150 mm × 4.6 mm, 3 µm) using gradient elution at a flow rate of 1 mL/min and a column temperature of 45 °C. UV detection was performed at 254 nm. The validation was performed according to the International Conference on Harmonization (ICH) guidelines. In addition, the solution stability and method robustness were examined. The method gives satisfactory separation of impurities of pioglitazone hydrochloride and so it is suitable for quantification of the process related impurities as well as for the assay of the active compound.


Announcements


Our editors have decided to support scientists to publish their manuscripts in European Journal of Chemistry without any financial constraints.

1- The article processing fee will not be charged from the articles containing the single-crystal structure characterization between November 15, 2022 and December 28, 2022 (Voucher code: SINGLE2022).

2. Young writers will not be charged for the article processing fee between November 15, 2022 and December 28, 2022 (Voucher code: YOUNG2022).

3. The article processing fee will not be charged from the articles containing a part of the PhD thesis between November 15, 2022 and December 28, 2022 (Voucher code: PhD2022).

4. The article processing fee will not be charged from authors who have at least one publication in the European Journal of Chemistry between November 15, 2022 and December 28, 2022 (Voucher code: (Voucher code: AUTHOR2022).

Editor-in-Chief

European Journal of Chemistry

Keywords


RP-HPLC; Thiazolidinedione; Method development; Forced degradation study; Process related impurities; Pioglitazone hydrochloride

Full Text:

PDF
PDF    Open Access

DOI: 10.5155/eurjchem.5.3.469-474.1058

Links for Article


| | | | | | |

| | | | | | |

| | | |

Related Articles




Article Metrics

icon graph This Abstract was viewed 969 times | icon graph PDF Article downloaded 533 times

Funding information


Pharmazell Research Centre, Visakhapatnam, 530003, Andhra Pradesh, India

Citations

/


References


[1]. Gillies, P. S.; Dunn, C. J. Drugs. 2000, 60, 333-343.
http://dx.doi.org/10.2165/00003495-200060020-00009

[2]. Diamant, M.; Heine, R. J. Drugs. 2003, 63, 1373-1405.
http://dx.doi.org/10.2165/00003495-200363130-00004

[3]. Madan, P. CMAJ 2005, 173, 344-345.
http://dx.doi.org/10.1503/cmaj.1050034

[4]. Brunton, L. L.; Lazo, J. S.; Parker, K. L. Goodman & Gilman's the pharmacological basis of therapeutics. 10th Edi. New York, McGraw-Hill, 2001.

[5]. Lacy, C. F.; Armstrong, L. L.; Goldman, M. P.; Lance, L. L. Drug information handbook 2000-2001. 8th Edi. Cleveland, Lexi-Comp., 2000.

[6]. Eckland, D. A.; Danhof, M. Exp. Clin. Endocrinol. Diab. 2000, 108, 234-242.
http://dx.doi.org/10.1055/s-2000-8525

[7]. Colca, J. R.; McDonald, W. G.; Waldon, D. J.; Leone, J. W.; Lull, J. M.; Bannow, C. A.; Lund, E. T.; Mathews, W. R. Am. J. Physiol. Endocrinol. Metab. 2004, 286(2), 252-260.
http://dx.doi.org/10.1152/ajpendo.00424.2003

[8]. Paddock, M. L.; Willy, S. E.; Axelrod, H. L.; Cohen, A. E.; Roy, M.; Abresch, E. C.; Capraro, D.; Murphy, A. N. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(36), 14342-14347.
http://dx.doi.org/10.1073/pnas.0707189104

[9]. The Merck Index, 14th Edi. Merck and Co Inc., NJ, USA, 2006.

[10]. URL: http://www.rxlist.com/actos-drug.htm

[11]. Zhong, W. Z.; Williams, M. G. J. Pharm. Biomed. Anal. 1996, 14, 465-473.
http://dx.doi.org/10.1016/0731-7085(95)01665-1

[12]. Yamashita, K.; Murakami, H.; Okuda, T.; Motohashi, M. J. Chromatogr. B. 1996, 677, 141-146.
http://dx.doi.org/10.1016/0378-4347(95)00440-8

[13]. Radhakrishna, T.; Sreenivas, R. D.; Reddy, O. G. J. Pharm. Biomed. Anal. 2002, 29, 593-607.
http://dx.doi.org/10.1016/S0731-7085(02)00036-5

[14]. Xue, Y. J.; Turner, K. C.; Meeker, J. B.; Pursley, J.; Arnold, M.; Unger, S. J. Chromatogr. B. 2003, 795, 215-226.
http://dx.doi.org/10.1016/S1570-0232(03)00575-0

[15]. Sane, R. T.; Menon, S. N.; Inamdar, S.; Mote, M.; Gundi, G. Chromatographia 2004, 59, 451-453.
http://dx.doi.org/10.1365/s10337-004-0209-9

[16]. Sripalakit, P.; Neamhom, P.; Saraphanchotiwitthaya, A. J. Chromatogr. B 2006, 843, 164-169.
http://dx.doi.org/10.1016/j.jchromb.2006.05.032

[17]. Lotfy, S. A. M. R. Pak. J. Anal. Environ. Chem. 2008, 2(9), 118-121.

[18]. Tahmasebi, E.; Yamini, Y.; Saleh, A. J. Chromatogr. B 2009, 877, 1923-1929.
http://dx.doi.org/10.1016/j.jchromb.2009.05.033

[19]. Cijo, M. X.; Kanakapura, B. ISRN Chromatography. 2012, 592849, 1-11.

[20]. Venugopal, S.; Kalpana, S.; Jagadishbabu, A.; Upendra, M. T.; Devanna, N. Int. J. Pharm. Biomed. Sci. 2012, 3(3), 89-96.

[21]. Ramzia, I.; El-Bagary, E.; Elkady, F.; Bassam, M. A. Int. J. Biomed. Sci. 2011, 7(3), 201-208.


How to cite


Prava, V.; Seru, G. Eur. J. Chem. 2014, 5(3), 469-474. doi:10.5155/eurjchem.5.3.469-474.1058
Prava, V.; Seru, G. Development and validation of a new RP-HPLC method for the determination of process related impurities in pioglitazone hydrochloride. Eur. J. Chem. 2014, 5(3), 469-474. doi:10.5155/eurjchem.5.3.469-474.1058
Prava, V., & Seru, G. (2014). Development and validation of a new RP-HPLC method for the determination of process related impurities in pioglitazone hydrochloride. European Journal of Chemistry, 5(3), 469-474. doi:10.5155/eurjchem.5.3.469-474.1058
Prava, Venkata, & Ganapaty Seru. "Development and validation of a new RP-HPLC method for the determination of process related impurities in pioglitazone hydrochloride." European Journal of Chemistry [Online], 5.3 (2014): 469-474. Web. 7 Dec. 2022
Prava, Venkata, AND Seru, Ganapaty. "Development and validation of a new RP-HPLC method for the determination of process related impurities in pioglitazone hydrochloride" European Journal of Chemistry [Online], Volume 5 Number 3 (30 September 2014)

The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item



DOI Link: https://doi.org/10.5155/eurjchem.5.3.469-474.1058


CrossRef | Scilit | GrowKudos | Researchgate | Publons | ScienceGate | Scite | Lens | OUCI

WorldCat Paperbuzz | LibKey Citeas | Dimensions | Semanticscholar | Plumx | Kopernio | Zotero | Mendeley

ZoteroSave to Zotero MendeleySave to Mendeley



European Journal of Chemistry 2014, 5(3), 469-474 | doi: https://doi.org/10.5155/eurjchem.5.3.469-474.1058 | Get rights and content

Refbacks

  • There are currently no refbacks.




Copyright (c)





© Copyright 2010 - 2022  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2010-2022 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.